These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7592041)

  • 1. Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Yasui M; Otani T
    J Antibiot (Tokyo); 1995 Aug; 48(8):901-3. PubMed ID: 7592041
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
    J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
    [No Abstract]   [Full Text] [Related]  

  • 4. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 6. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees.
    Yun HC; Ellis MW; Jorgensen JH
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):463-6. PubMed ID: 17911001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature effect on the susceptibility of methicillin-resistant Staphylococcus aureus to four different cephalosporins.
    Canawati HN; Witte JL; Sapico FL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):173-5. PubMed ID: 6919411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.
    Springer DM; Luh BY; Goodrich JT; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):281-91. PubMed ID: 12470721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
    Cho A; Glinka TW; Ludwikow M; Fan AT; Wang M; Hecker SJ
    Bioorg Med Chem Lett; 2001 Jan; 11(2):137-40. PubMed ID: 11206444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of methicillin, oxacillin and cefamandole against clinical isolates of Staphylococcus aureus.
    Kluge RM
    J Antimicrob Chemother; 1980 May; 6(3):412-5. PubMed ID: 7400076
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal disk susceptibility testing of Staphylococcus epidermidis and aureus against penicillinase-resistant semisynthetic penicillins and cephalosporins.
    Wybo I; Pierard D; Lauwers S
    J Chemother; 1989 Jul; 1(4 Suppl):324-5. PubMed ID: 16312422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular design of anti-MRSA drugs].
    Hanaki H
    Nihon Rinsho; 1997 May; 55(5):1281-6. PubMed ID: 9155187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should resistance to methicillin of RH mutant staphylococci be necessarily attributed to cephalosporins?].
    Joly B; Cluzel R; Henri Ph; Sirot D
    Pathol Biol (Paris); 1975 Apr; 23(4):291-7. PubMed ID: 1097992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives.
    Springer DM; Luh BY; Goodrich J; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):265-79. PubMed ID: 12470720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins.
    Collins JK; Mader JT; Kelly MT
    J Infect Dis; 1983 Mar; 147(3):591. PubMed ID: 6550616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.